Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Journal of Experimental Hematology ; (6): 1138-1142, 2023.
Article in Chinese | WPRIM | ID: wpr-1009971

ABSTRACT

OBJECTIVE@#To evaluate the efficacy, safety and relapse of cyclosporine A (CsA) and CsA combined with corticosteroid (CS) as the frontline therapy for patients with newly diagnosed acquired pure red cell aplasia (aPRCA).@*METHODS@#The clinical features, treatment responses, relapses and clinical outcomes of patients with newly diagnosed aPRCA in Peking Union Medical College Hospital (PUMCH) from January 2015 to May 2020 were analyzed retrospectively. All the enrolled patients had been treated with either CsA or CsA+CS for at least 6 months and had been followed up for at least 12 months, with complete clinical data and consent forms.@*RESULTS@#96 patients including 72 treated with CsA and 24 treated with CsA+CS were enrolled. With comparable baseline characteristics and follow-up periods, patients treated with CsA or with CsA+CS had similar overall response rates (ORRs) and complete response rates (CRRs) at the 3rd, 6th and 12th month and at the end of follow-up (P>0.05). Meanwhile, no significant difference was found between the two groups in the optimal ORR, optimal CRR, time to response or time to complete response. CsA+CS and CsA groups had similar adverse event (AE) rates, but CsA+CS group had higher CS-related infection rate (P <0.05). One patient in CsA+CS group died of multiple infections. As for the relapse, the two groups had compatible relapse rates at different time points, time to relapse, overall relapse rate and relapse-free survival (P>0.05). CsA exposure time, rather than different therapy regimens, was the only influence factor for either ORR or relapse rate (P <0.05).@*CONCLUSION@#CsA monotherapy has similar efficacy, AE rate and relapse rate as compared with CsA+CS for patients with newly diagnosed aPRCA, and shows less CS-related AEs such as infection.


Subject(s)
Humans , Cyclosporine/therapeutic use , Retrospective Studies , Red-Cell Aplasia, Pure/drug therapy , Adrenal Cortex Hormones/therapeutic use , Remission Induction , Treatment Outcome , Immunosuppressive Agents/therapeutic use
2.
Clinical Pediatric Hematology-Oncology ; : 142-145, 2015.
Article in English | WPRIM | ID: wpr-788555

ABSTRACT

Acquired pure red cell aplasia (PRCA) can be induced by various factors such as viral infection, thymoma, connective tissue disease, lymphoma, and adverse drug reactions. PRCA has not been reported in an adolescent in Korea for the past several decades. We recently experienced a case of acquired PRCA in an adolescent. A 14-year-old girl presented with pallor, dizziness, and mild fever. She had isolated normocytic normochromic anemia with reticulocytopenia in the peripheral blood and erythroblastopenia in the bone marrow. She was diagnosed with secondary acquired PRCA presumably induced by Mycoplasma pneumoniae infection during her clinical course, and she experienced spontaneous remission 11 weeks after initial diagnosis. Her clinical and hematologic statuses were normal as far as 20 months after her diagnosis.


Subject(s)
Adolescent , Female , Humans , Anemia , Bone Marrow , Connective Tissue Diseases , Diagnosis , Dizziness , Drug-Related Side Effects and Adverse Reactions , Fever , Korea , Lymphoma , Mycoplasma Infections , Mycoplasma pneumoniae , Pallor , Pneumonia, Mycoplasma , Red-Cell Aplasia, Pure , Remission, Spontaneous , Thymoma
3.
Clinical Pediatric Hematology-Oncology ; : 142-145, 2015.
Article in English | WPRIM | ID: wpr-71731

ABSTRACT

Acquired pure red cell aplasia (PRCA) can be induced by various factors such as viral infection, thymoma, connective tissue disease, lymphoma, and adverse drug reactions. PRCA has not been reported in an adolescent in Korea for the past several decades. We recently experienced a case of acquired PRCA in an adolescent. A 14-year-old girl presented with pallor, dizziness, and mild fever. She had isolated normocytic normochromic anemia with reticulocytopenia in the peripheral blood and erythroblastopenia in the bone marrow. She was diagnosed with secondary acquired PRCA presumably induced by Mycoplasma pneumoniae infection during her clinical course, and she experienced spontaneous remission 11 weeks after initial diagnosis. Her clinical and hematologic statuses were normal as far as 20 months after her diagnosis.


Subject(s)
Adolescent , Female , Humans , Anemia , Bone Marrow , Connective Tissue Diseases , Diagnosis , Dizziness , Drug-Related Side Effects and Adverse Reactions , Fever , Korea , Lymphoma , Mycoplasma Infections , Mycoplasma pneumoniae , Pallor , Pneumonia, Mycoplasma , Red-Cell Aplasia, Pure , Remission, Spontaneous , Thymoma
SELECTION OF CITATIONS
SEARCH DETAIL